author_facet Dai
Dai
author Dai
spellingShingle Dai
International Journal of Oncology
Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
Cancer Research
Oncology
author_sort dai
spelling Dai 1019-6439 1791-2423 Spandidos Publications Cancer Research Oncology http://dx.doi.org/10.3892/ijo_00000770 Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent International Journal of Oncology
doi_str_mv 10.3892/ijo_00000770
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9pam9fMDAwMDA3NzA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9pam9fMDAwMDA3NzA
institution DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint Spandidos Publications, 2010
imprint_str_mv Spandidos Publications, 2010
issn 1019-6439
1791-2423
issn_str_mv 1019-6439
1791-2423
language Undetermined
mega_collection Spandidos Publications (CrossRef)
match_str 2010amifostineenhancementoftheanticancereffectsofpaclitaxelinendometrialcanceristp53dependent
publishDateSort 2010
publisher Spandidos Publications
recordtype ai
record_format ai
series International Journal of Oncology
source_id 49
title Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_unstemmed Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_full Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_fullStr Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_full_unstemmed Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_short Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_sort amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is tp53-dependent
topic Cancer Research
Oncology
url http://dx.doi.org/10.3892/ijo_00000770
publishDate 2010
physical
description
container_issue 5
container_start_page 0
container_title International Journal of Oncology
container_volume 37
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792331973081956357
geogr_code not assigned
last_indexed 2024-03-01T13:49:27.992Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Amifostine+enhancement+of+the+anti-cancer+effects+of+paclitaxel+in+endometrial+cancer+is+TP53-dependent&rft.date=2010-09-22&genre=article&issn=1791-2423&volume=37&issue=5&jtitle=International+Journal+of+Oncology&atitle=Amifostine+enhancement+of+the+anti-cancer+effects+of+paclitaxel+in+endometrial+cancer+is+TP53-dependent&aulast=Dai&rft_id=info%3Adoi%2F10.3892%2Fijo_00000770&rft.language%5B0%5D=und
SOLR
_version_ 1792331973081956357
author Dai
author_facet Dai, Dai
author_sort dai
container_issue 5
container_start_page 0
container_title International Journal of Oncology
container_volume 37
description
doi_str_mv 10.3892/ijo_00000770
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9pam9fMDAwMDA3NzA
imprint Spandidos Publications, 2010
imprint_str_mv Spandidos Publications, 2010
institution DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 1019-6439, 1791-2423
issn_str_mv 1019-6439, 1791-2423
language Undetermined
last_indexed 2024-03-01T13:49:27.992Z
match_str 2010amifostineenhancementoftheanticancereffectsofpaclitaxelinendometrialcanceristp53dependent
mega_collection Spandidos Publications (CrossRef)
physical
publishDate 2010
publishDateSort 2010
publisher Spandidos Publications
record_format ai
recordtype ai
series International Journal of Oncology
source_id 49
spelling Dai 1019-6439 1791-2423 Spandidos Publications Cancer Research Oncology http://dx.doi.org/10.3892/ijo_00000770 Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent International Journal of Oncology
spellingShingle Dai, International Journal of Oncology, Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent, Cancer Research, Oncology
title Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_full Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_fullStr Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_full_unstemmed Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_short Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
title_sort amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is tp53-dependent
title_unstemmed Amifostine enhancement of the anti-cancer effects of paclitaxel in endometrial cancer is TP53-dependent
topic Cancer Research, Oncology
url http://dx.doi.org/10.3892/ijo_00000770